Concord Biotech's US$650m Lock-Up Expiry - Some Could Be Tempted to Book Multi-Bagger Gains
Concord Biotech Ltd (658823Z IN) listed in India on 18th Aug 23. Coming up for six-month lockup expiry on 7th Feb 24 are the firm’s pre-IPO...
261 Views
Aequitas 2024 Asia IPO Pipeline - India
In this note, we will take a look at the Asia Pacific IPO pipeline for 2024, following up with India after having looked at Hong Kong earlier.
408 Views
Concord Biotech IPO Trading - Strong Subscription Rates, Peers Have Moved up Since Last Note
Concord Biotech Ltd (658823Z IN) raised US$188m in its India IPO. In this note, we will talk about the trading dynamics.
379 Views
Concord Biotech IPO - Peer Comparison & Valuation - Smaller in Scale but Wider in Margins
Concord Biotech Ltd (658823Z IN) is looking to raise around US$188m in its India IPO. In this note, we will undertake a peer comparison, and share...
574 Views
Concord Biotech IPO - RHP Updates - Continued Growing Although Concentration Risk Remains Elevated
Concord Biotech Ltd (658823Z IN) is looking to raise around US$188m in its India IPO. Concord is an India-based biopharma firm, which develops and...
333 Views